Professional Documents
Culture Documents
R.M.E. Richards
Introduction
Pharmaceutical products are generally required to be free from contamination
with micro-organisms (bacteria, viruses, yeasts, moulds, etc.). Such organism
may cause spoilage by adversely affecting the appearance or composition of a
product and may cause serious adverse effects in the patient. Adverse effects
are particularly likely if the preparation is introduced into the body via a route
which bypasses some of the bodys normal defence mechanisms, especially in a
seriously ill or immunocompromised patient.
Dosage forms designed for parenteral, ophthalmic or surgical use, as well
as irrigation solutions and topical preparations for application to large open
wounds, must be free from microbial and particulate contamination. These
products are requaired to be prepared and maintained in a sterile state until
used. Some of the terms used in connection with sterile pharmaceutical
products are defined below.
Sterility. Sterility my be defined as the total absence of viable microorganisms and is an absolute state. The production of sterile pharmaceutical
products may be achieved by aseptic technique (see Ch. 22) or by means of a
terminal sterilization process (see Chs 20, 21).
Sterilization. This is the subjection of products to a process whereby all
viable life forms are either killed or removed. The sterilization process is ussually
the final stage in the preparation of the product. The fundamental properties of
micro-organisms and the actions of chemical and physical agents upon them are
discussed in the companion volume (Aulton 1998), which also discusses the
principles and practice of sterilization. The methods of sterilization in reguler use
include exposure to : saturated steam under pressure, dry heat, ionizing
radiation, ethylene oxide or passage through a bacteriaretaining filter. When
possible, exposure to saturated steam under pressure is the sterilization method
of choice.
Aseptic technique. This is the preparation of pharmaceutical products
from sterile ingridients by procedures that exclude the access of viable microorganisms into the products. It is used for those products that would be
adversely affected by being subjected to a sterilization process.
Sterility testing. Tests for sterility of pharmaceutical products attempt to
reveal the presence or absence of viable micro-organism in a sample number of
containers taken from a production batch. From the results of such tests an
inference is made as to the sterility of the batch.
In Nt = In N0 t
D value. Bacterial spores have a Z value in the range 10-15 0C while most nonsporing organisms have Z values of 4-60C.
Q or temperature coefficient
The F value is a measure of the lethality of the total process of sterilization and
equates heat treatment at any particular temperature with the time in minutes
at a designated reference temperature that would be required to produce the
same lethality in a organism of stated Z value. For a temperature of 121 0C and
organism with a Z value of 10 0C F becomes Fo. Annex 2 of Appendix of F0: The F0
value of a sturated steam process is the lethality expressed in terms of the
equivalent time in minutes at 1210C delivered by that process to the product in
its final containers with refernce to micro-organisms possesing a Z value of 10 0C.
One F unit is equivalent to heating the load for 1 minute at 121 0C.
Mathematically F is defined as :
Fo = 10(Tc-121/Z) dt
Where Tc = load temperature at time dt and Z = 100C.
The total lethality (Fo) for the cycle is equal to the sum the F o values for
each individual time/temperature segment. The accuary of the estimated F O is
related to the time interval represented by each segment of the profile. Small
intervals are conventionalty handled by computer, the BP 1998 suggest the use
of Fo calculation for the overall lethalty delivered to aqueos preparations for a
microbiologically validated steam sterilizations process and states that a total F o
value of not less than 8 applied to every container in load would be considered
satisfactory.
Where the product is especially heat sensitive an F o of less than 8 is
deemed justifiable so long as great care is tajen to ensure that an adequate
assurance of sterility is consistently achieved. That is : it is necessary not only to
validate the process microbiologically, but also to perform continuous, rigorous,
microbiological monitoring during routine production to demonstrate that micro
biological parameters are within the estabilshd tolerances so as to give a
theorretical level of not more than one living organism in 10 6 containers of the
final product (1988).
Kirk et al (1985) investigated the degradiation under autoclaving
conditions of 2,4-dihyroxybenzoic acid in autoclave cycles delivering a standart
process lethality (Fo=8) by means of different degress of degradation of the
chemical. That is hight temperature, short time cycles (112 oC/Fo=8) caused
approximately 12% degradation but prolonged exposure at a relatively low
temperature (112oC/Fo=8) caused approximately 30% degredation. Thus in the in
terest of stability these works suggested that, where other factores permit, the
optimum sterilization cycle would consist of the load being subjected to a
temperature which continuously increased, no holding phase, until a prefixed F 0
had been achieved. The load would then be cooled under controlled conditions
concept in Chapter 26 of
In the UK, guidelines on the acceptability of a sterilization cycle are given in the
Health Technical Memorandum 10 on sterilizers (DHSS). A Master Temperatured
Record (MTR) is prepared as part of the validation procedure for a particular
autoclave and for each specified product and load configuration. This is then
used as a reference for the process record obtained from a single thermocouple
placed in a strategic part of each load (Temperature Recording Chart, TRC).
In scotland the MTR is established on the evidence of three succesful sterilization
cycles as recorded on a 12-point recorder on a situations. For examples, ten
thermocouples could be the load, one thermocouple could be left free in the
centre of the autoclave and one thermocouple should be placed sparately in
containers distributed throughout the load, one thermocouple could be left free
in the centre of the autoclave and one thermocouple should be represent the
coolest spot. The MTR should be checked at annual intervals and whenever
significant changes occur in the TRC when compared with the MTR.
It is likely that microprocessor controlled sterilization cycles will replace the MTR
approach to controlling sterilization cycles. This is because the microprocessor
gives the possibility of a much tighter control and description of sterilization
cycles than comparison of the TRC with the MTR as used at present in the UK.
Conclusion
From the foregoing it can be seen that the factors affecting sterilization include:
Factors relating to the biorburden.
These are concerned with the Initial number of organisms present, their heat
resistance and in growth requirements.
Factors relating to the sterilization process.
These are concerned with the method chosen, the probability of sterilization
which is related to the overall lethality or efficiency of the process and the
methods of validating and monitoring the sterilization processes.
Factors relating to the product to be sterilized.
These are concerned with the physical and chemical properties of the product.
That is its solubility, hydrogen ion concentration and nutritive properties and in
particular its stability to heat and moisture.
In addition, it should be mentioned that the properties of the container are
Interrelated with the factors relating to the sterilization process and those
relating to the product.